Areas | |
---|---|
Serie de libros (92) |
1307
|
Letra |
2291
|
Ciencias Naturales |
5354
|
Matemática | 224 |
Informática | 313 |
Física | 975 |
Química | 1354 |
Geociencias | 131 |
Medicina humana | 242 |
Estomatología | 10 |
Veterinaria | 99 |
Farmacia | 147 |
Biología | 830 |
Bioquímica, biología molecular, tecnología genética | 117 |
Biofísica | 25 |
Nutrición | 44 |
Agricultura | 996 |
Silvicultura | 201 |
Horticultura | 20 |
Ecología y conservación de la tierra | 145 |
Ciencias Ingeniería |
1745
|
General |
91
|
Leitlinien Unfallchirurgie
5. Auflage bestellen |
Indice, PDF (57 KB)
Lectura de prueba, PDF (210 KB)
Violacein and deoxyviolacein are promising therapeutics against pathogenic bacteria and viruses as well as tumor cells. In the present work, systems-wide metabolic engineering was applied to Escherichia coli for heterologous production of these high-value products. First, a high performance liquid chromatography method for accurate separation and quantification of violacein and deoxyviolacein was developed. Afterwards, a basic producer, E. coli dVio-1, that expressed the vioABCE cluster from Chromobacterium violaceum under control of the araBAD promoter and induction by L-arabinose, was constructed. Targeted intracellular metabolite analysis then identified bottlenecks in pathways that supply tryptophan, the major product building block of the natural products of interest. This was used for systems-wide engineering of serine, chorismate and tryptophan biosynthesis and the non-oxidative pentose-phosphate pathway, followed by elimination of L-arabinose catabolism. Transferred to a glycerol-based fed-batch process, E. coli dVio-8 surpassed the gram scale and produced 1.6 g L-1 deoxyviolacein (> 99.5% purity). The created chassis of a high-flux tryptophan pathway was complemented by genomic integration of the vioD gene of Janthinobacterium lividum, which enabled exclusive production of violacein (710 mg L-1 with 99.8% purity). This demonstrates the potential of E. coli as a platform for production of tryptophan based therapeutics.
ISBN-13 (Impresion) | 9783954049608 |
ISBN-13 (E-Book) | 9783736949607 |
Idioma | Inglés |
Numero de paginas | 128 |
Laminacion de la cubierta | mate |
Edicion | 1. Aufl. |
Serie | Hochschulschriften - Institut für Systembiotechnologie, Universität des Saarlandes |
Volumen | 4 |
Lugar de publicacion | Göttingen |
Fecha de publicacion | 13.07.2015 |
Clasificacion simple | Tesis doctoral |
Area |
Microbiología y biotécnica
|
Palabras claves | violacein, deoxyviolacein, Escherichia coli, metabolic engineering |